Pell Bio-Med Technology Co., Ltd. (6949.TW) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Pell Bio-Med Technology Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -47.37x |
| P/B Ratio | 14.12x |
| P/S Ratio | 639.09x |
| Profitability | |
| Gross Margin | -14.0% |
| Operating Margin | -1487.2% |
| Net Margin | -1349.1% |
| EBITDA Margin | -1337.3% |
| Liquidity | |
| Current Ratio | 4.31x |
| Quick Ratio | 4.29x |
| Leverage | |
| Debt/Equity | 0.17x |
YoY = year-over-year change. Source: FMP..